Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused by human papillomavirus (HPV) in women ...

New research suggests that autoimmune diseases may be driven by DNA mutations in immune cells that remove the natural brakes ...

Pelvic organ prolapse (POP) is a common condition that affects women’s quality of life. Traditional surgical and non-surgical treatments face challenges such as limite ...

Researchers identified a small panel of inflammatory and neurology-related blood proteins that may help distinguish long ...

Benjamin Lockshin, MD, FAAD, examines the non-clinical reasons driving real-world treatment discontinuation and explains how ...